• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在新冠疫情时代锻炼:对非酒精性脂肪性肝病(NAFLD)的影响。

Exercising in the COVID-19 era: implications in non-alcoholic fatty liver disease (NAFLD).

机构信息

School of Physiotherapy, Royal College of Surgeons in Ireland, Dublin, Ireland.

Discipline of Physiotherapy, Trinity College Dublin, Dublin, Ireland.

出版信息

BMJ Open Gastroenterol. 2021 Jun;8(1). doi: 10.1136/bmjgast-2020-000568.

DOI:10.1136/bmjgast-2020-000568
PMID:34168043
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8228576/
Abstract

COVID-19 is a major public health pandemic. Risk factors for severe infection and poorer outcomes include cardiovascular disease, obesity, type 2 diabetes mellitus and non-alcoholic fatty liver disease (NAFLD). Lifestyle interventions, including diet and physical activity modifications, are the current recommended treatment for NAFLD. In this communication, the authors discuss the crossover link between NAFLD and severe COVID-19 infection and the impact of essential public health measures to suppress the spread of COVID-19 on exercise and physical activity participation in patients with NAFLD. The future of exercise prescription and the potential use of digital technology in addressing NAFLD healthcare needs in the COVID-19 era are also explored.

摘要

新型冠状病毒肺炎是一种重大的公共卫生大流行疾病。严重感染和预后较差的风险因素包括心血管疾病、肥胖、2 型糖尿病和非酒精性脂肪性肝病(NAFLD)。生活方式干预,包括饮食和身体活动的改变,是目前推荐的治疗非酒精性脂肪性肝病的方法。在本通讯中,作者讨论了非酒精性脂肪性肝病和严重新型冠状病毒肺炎感染之间的交叉联系,以及为抑制新型冠状病毒肺炎传播而采取的基本公共卫生措施对非酒精性脂肪性肝病患者运动和身体活动参与的影响。还探讨了运动处方的未来以及在新型冠状病毒肺炎时代利用数字技术满足非酒精性脂肪性肝病医疗需求的潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8adb/8228576/10a6f120cb4f/bmjgast-2020-000568f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8adb/8228576/10a6f120cb4f/bmjgast-2020-000568f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8adb/8228576/10a6f120cb4f/bmjgast-2020-000568f01.jpg

相似文献

1
Exercising in the COVID-19 era: implications in non-alcoholic fatty liver disease (NAFLD).在新冠疫情时代锻炼:对非酒精性脂肪性肝病(NAFLD)的影响。
BMJ Open Gastroenterol. 2021 Jun;8(1). doi: 10.1136/bmjgast-2020-000568.
2
Non-Alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus: A Position Statement of the Fatty Liver Research Group of the Korean Diabetes Association.非酒精性脂肪性肝病与 2 型糖尿病:韩国糖尿病协会脂肪肝病研究组立场声明。
Diabetes Metab J. 2020 Jun;44(3):382-401. doi: 10.4093/dmj.2020.0010. Epub 2020 May 11.
3
Non-alcoholic Fatty Liver Disease and COVID-19 Susceptibility and Outcomes: a Korean Nationwide Cohort.非酒精性脂肪性肝病与 COVID-19 易感性和结局:一项韩国全国队列研究。
J Korean Med Sci. 2021 Oct 25;36(41):e291. doi: 10.3346/jkms.2021.36.e291.
4
Nonalcoholic steatohepatitis (NASH) - current treatment recommendations and future developments.非酒精性脂肪性肝炎(NASH)——当前的治疗建议及未来发展
Z Gastroenterol. 2019 Apr;57(4):508-517. doi: 10.1055/a-0784-8827. Epub 2019 Apr 9.
5
Cardiovascular risk across the histological spectrum and the clinical manifestations of non-alcoholic fatty liver disease: An update.非酒精性脂肪性肝病组织学谱中的心血管风险及临床表现:最新进展
World J Gastroenterol. 2015 Jun 14;21(22):6820-34. doi: 10.3748/wjg.v21.i22.6820.
6
Nonalcoholic Fatty Liver Disease and Diabetes: Part II: Treatment.非酒精性脂肪性肝病和糖尿病:第二部分:治疗。
Diabetes Metab J. 2019 Apr;43(2):127-143. doi: 10.4093/dmj.2019.0034.
7
Nonalcoholic fatty liver disease as a multi-systemic disease.非酒精性脂肪性肝病作为一种多系统疾病。
World J Gastroenterol. 2016 Apr 28;22(16):4079-90. doi: 10.3748/wjg.v22.i16.4079.
8
Different Dietary Approaches, Non-Alcoholic Fatty Liver Disease and Cardiovascular Disease: A Literature Review.不同的饮食方法、非酒精性脂肪性肝病与心血管疾病:文献综述。
Nutrients. 2023 Mar 20;15(6):1483. doi: 10.3390/nu15061483.
9
Non-Alcoholic Fatty Liver Disease and COVID-19-Two Pandemics Hitting at the Same Time.非酒精性脂肪性肝病与 COVID-19:双重疫情夹击
Medicina (Kaunas). 2021 Oct 3;57(10):1057. doi: 10.3390/medicina57101057.
10
Nonalcoholic Fatty Liver Disease Pandemic Fuels the Upsurge in Cardiovascular Diseases.非酒精性脂肪性肝病大流行助推心血管疾病浪潮。
Circ Res. 2020 Feb 28;126(5):679-704. doi: 10.1161/CIRCRESAHA.119.316337. Epub 2020 Feb 27.

引用本文的文献

1
Long-term antibody response after the third dose of inactivated SARS-CoV-2 vaccine in MASLD patients.MASLD 患者接种第三剂灭活 SARS-CoV-2 疫苗后的长期抗体反应。
BMC Gastroenterol. 2024 Sep 30;24(1):329. doi: 10.1186/s12876-024-03402-9.
2
COVID-19 and MAFLD/NAFLD: An updated review.2019冠状病毒病与代谢功能障碍相关脂肪性肝病/非酒精性脂肪性肝病:最新综述
Front Med (Lausanne). 2023 Mar 24;10:1126491. doi: 10.3389/fmed.2023.1126491. eCollection 2023.
3
Impact of Physical Activity on COVID-19.体力活动对新冠病毒肺炎的影响。

本文引用的文献

1
Modifiable and non-modifiable risk factors for COVID-19, and comparison to risk factors for influenza and pneumonia: results from a UK Biobank prospective cohort study.可改变和不可改变的 COVID-19 风险因素,以及与流感和肺炎风险因素的比较:来自英国生物银行前瞻性队列研究的结果。
BMJ Open. 2020 Nov 19;10(11):e040402. doi: 10.1136/bmjopen-2020-040402.
2
Inverse Relationship of Maximal Exercise Capacity to Hospitalization Secondary to Coronavirus Disease 2019.与 2019 年冠状病毒病住院相关的最大运动能力呈反比关系。
Mayo Clin Proc. 2021 Jan;96(1):32-39. doi: 10.1016/j.mayocp.2020.10.003. Epub 2020 Oct 10.
3
Physical activity, mental health and well-being of adults during initial COVID-19 containment strategies: A multi-country cross-sectional analysis.
Int J Environ Res Public Health. 2022 Oct 28;19(21):14108. doi: 10.3390/ijerph192114108.
4
Impact of COVID-19 Lockdown on Non-Alcoholic Fatty Liver Disease and Insulin Resistance in Adults: A before and after Pandemic Lockdown Longitudinal Study.新冠疫情封锁对成年人非酒精性脂肪肝和胰岛素抵抗的影响:一项疫情封锁前后的纵向研究。
Nutrients. 2022 Jul 7;14(14):2795. doi: 10.3390/nu14142795.
5
Differential Effects of Dietary versus Exercise Intervention on Intrahepatic MAIT Cells and Histological Features of NAFLD.饮食干预与运动干预对非酒精性脂肪性肝病患者肝内 MAIT 细胞及组织学特征的影响差异。
Nutrients. 2022 May 25;14(11):2198. doi: 10.3390/nu14112198.
6
Prevalence of frailty in patients with non-cirrhotic non-alcoholic fatty liver disease.非酒精性脂肪性肝病非肝硬化患者衰弱的患病率。
BMJ Open Gastroenterol. 2022 May;9(1). doi: 10.1136/bmjgast-2021-000861.
成人在 COVID-19 初始遏制策略期间的身体活动、心理健康和幸福感:一项多国家横断面分析。
J Sci Med Sport. 2021 Apr;24(4):320-326. doi: 10.1016/j.jsams.2020.11.016. Epub 2020 Dec 3.
4
World Health Organization 2020 guidelines on physical activity and sedentary behaviour.世界卫生组织 2020 年关于身体活动和 sedentary behaviour 的指南。
Br J Sports Med. 2020 Dec;54(24):1451-1462. doi: 10.1136/bjsports-2020-102955.
5
Determinants of Physical Activity Engagement in Patients With Nonalcoholic Fatty Liver Disease: The Need for an Individualized Approach to Lifestyle Interventions.非酒精性脂肪性肝病患者身体活动参与的决定因素:生活方式干预需要个体化方法。
Phys Ther. 2021 Feb 4;101(2). doi: 10.1093/ptj/pzaa195.
6
Obese patients with NASH have increased hepatic expression of SARS-CoV-2 critical entry points.患有非酒精性脂肪性肝炎(NASH)的肥胖患者肝脏中严重急性呼吸综合征冠状病毒2(SARS-CoV-2)关键进入点的表达增加。
J Hepatol. 2021 Feb;74(2):469-471. doi: 10.1016/j.jhep.2020.09.027. Epub 2020 Oct 20.
7
Determinants of physical activity maintenance during the Covid-19 pandemic: a focus on fitness apps.新冠疫情期间身体活动维持的决定因素:以健身应用程序为重点。
Transl Behav Med. 2020 Oct 8;10(4):835-842. doi: 10.1093/tbm/ibaa086.
8
Changes in Physical Activity and Sedentary Behavior in Response to COVID-19 and Their Associations with Mental Health in 3052 US Adults.《3052 名美国成年人对 COVID-19 的身体活动和久坐行为变化及其与心理健康的关联》。
Int J Environ Res Public Health. 2020 Sep 5;17(18):6469. doi: 10.3390/ijerph17186469.
9
Improvement in histological endpoints of MAFLD following a 12-week aerobic exercise intervention.有氧运动干预 12 周后 MAFLD 的组织学终点改善。
Aliment Pharmacol Ther. 2020 Oct;52(8):1387-1398. doi: 10.1111/apt.15989. Epub 2020 Jul 27.
10
Factors associated with COVID-19-related death using OpenSAFELY.使用 OpenSAFELY 分析与 COVID-19 相关死亡的因素。
Nature. 2020 Aug;584(7821):430-436. doi: 10.1038/s41586-020-2521-4. Epub 2020 Jul 8.